Benjamin P. Linas MD
Professor, Infectious Diseases
Professor, Epidemiology
771 Albany St | (617) 414-5238belinas@bu.edu
benjamin.linas@bmc.org
Sections
Infectious Diseases
Biography
Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.
Websites
Boston-Providence Center for AIDS Research
NIDA Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV
Education
Medicine, MD, New York University School of Medicine
Clinical Evaluation/Research, MPH, Harvard School of Public Health
Economics, BA, Yale University
Publications
Linas BP. Centering AIDS Drug Assistance Programs in the US HIV Response. Clin Infect Dis. 2026 May 20; 82(5):e974-e975. PMID: 41877605.
Published on 5/4/2026Gallini J, Singh UB, Dauphinais M, Sarkar S, Carwile M, Kumar R, Rao R, Chaudhary A, McQuaid CF, Maloomian K, Sinha S, Mehta S, Dowdy DW, Liu AF, Linas BP, Horsburgh CR, White LF, Sinha P. Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study. BMJ Glob Health. 2026 May 04; 11(5). PMID: 42082204.
Published on 5/1/2026Zhu L, Magaldi LN, Wagh IA, Ennis ER, Reitsma MB, Kuncio DE, Addish E, Varghese SR, Furukawa NW, Honeycutt AA, Chen Y, Linas BP, Salomon JA. Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies. JAMA Intern Med. 2026 May 01; 186(5):585-595. PMID: 41870443.
Published on 4/30/2026Chhatwal J, Sahinkoc M, Chen Q, Dowd W, Xiao J, Zarkin GA, Aldridge A, Barocas JA, Cerdá M, Fareed N, Frazier LA, Hyder A, Keyes KM, Knott CE, LaRochelle M, Linas BP, Oga E, Roberts SM, Samet JH, Schackman BR, Seiber EE, Starbird LE, Villani J, Knudsen AB, Barbosa C. Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. Lancet Reg Health Am. 2026 Jul; 59:101480. PMID: 42099551.
Published on 4/27/2026Lind ML, Hitchings MDT, Singh RP, Linas BP, Cummings DAT, Epstein RL. Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US. JAMA Pediatr. 2026 Apr 27. PMID: 42043807.
Published on 4/1/2026Epstein RL, Munroe S, Erdman EA, Bettano A, Curtis MR, White L, Wachman EM, Osinski A, Walley AY, Linas BP. Hepatitis C Virus Testing in Perinatally Exposed Children. JAMA Netw Open. 2026 Apr 01; 9(4):e260743. PMID: 41996118.
Published on 3/17/2026Zhu L, Havens JR, Rudolph AE, Young AM, Yazdi GE, Thompson WW, Hagan LM, Randall LM, Wang J, Earnest R, Nolen S, Linas BP, Salomon JA. Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation. Am J Epidemiol. 2026 Mar 17; 195(4):937-947. PMID: 40069947.
Published on 3/5/2026Barbosa C, Chen Q, Sahinkoc M, Zarkin GA, Dowd W, Villani J, Barocas JA, Cerdá M, Chatterjee A, Fareed N, Hyder A, Keyes KM, Larochelle MR, Linas BP, Roberts SM, Schackman BR, Seiber E, Wakeman SE, Knudsen AB, Chhatwal J. Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach. Addiction. 2026 Mar 05. PMID: 41786317.
Published on 12/14/2025Chrysanthopoulou SA, Wang J, Nolen S, Madushani ARWM, Murphy SM, Linas BP, White LF. Modeling Recurrent Events: A Tutorial Based on Relapse and Remitting Episodes during Medication-Assisted Treatment for Opioid Use Disorder. Med Decis Making. 2026 Apr; 46(3):296-309. PMID: 41392532.
Published on 12/9/2025Haukoos J, Linas BP, Rowan SE. Screening for Hepatitis C in Emergency Departments-Reply. JAMA. 2025 Dec 09; 334(22):2040-2041. PMID: 41165682.
Media Mentions
Published on 7/25/2025
The ‘Big Beautiful Bill’ May Lead to More Fatal Overdoses
Published on 7/16/2025
Addiction funding withheld by Trump administration
Published on 7/26/2024
How to combat a new surge of COVID-19 cases
Published on 11/6/2023
How to protect yourself from the 'tripledemic' of COVID-19, flu and RSV this winter
Published on 5/11/2023
Ask The Docs: the COVID emergency ends, and a new RSV vaccine in the works
Published on 2/14/2023
Boston Doctors Explain What to Know as Norovirus Cases Spread in Mass.
Published on 2/14/2023
The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word
Published on 2/7/2023
US to Stop Offering Free COVID Vaccines This Fall: What it Means For Mass.
Published on 1/24/2023
Boston doctors answer listener questions about COVID
Published on 1/8/2023
Health Check: Diversity in Clinical Trials
View full list of 164 media mentions.